Today's Hours: 8:00am - 10:00pm

Search

Filter Applied Clear All

Did You Mean:

Search Results

  • Book
    Masakazu Toi, Eric Winer, John Benson, Suzanne Klimberg, editors.
    Contents:
    Part I Treatment for the Patients Having Breast Cancer High-Risk
    Chapter I Risk-Reducing Surgery for Breast Cancer Patients with BRCA Mutations
    Chapter 2 Prophylactic Risk Reducing Surgery for Breast Cancer
    Chapter 3 Merits and Demerits of Practice for Hereditary Breast and Ovarian Cancer Syndrome (Advices and Issues)
    Part II Axillary Treatment
    Chapter 4 Sentinel Lymph Node Biopsy and Neoadjuvant Chemotherapy in Breast Cancer Patients
    Chapter 5 Axillary Reverse Mapping (ARM) as a Means to Reduce Lymphedema During Sentinel Lymph Node or Axillary Node Dissection
    Chapter 6 Ultrasound for Axillary Staging
    Chapter 7 One Step Nucleic Acid Amplification(OSNA)Assay for Primary Breast Cancer
    Chapter 8 Management of the Clinically Node-Negative Axilla in Primary Breast Cancer
    Chapter 9 Lymphatic Mapping and Optimization of Sentinel Lymph Node Dissection
    Part III Radiation therapy
    Chapter 10 Personalization of Radiotherapy for Breast Cancer
    Chapter 11 New Technologies in Radiation Therapy
    Chapter 12 Radiotherapy Following Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
    Part IV Preoperative Hormone Therapy
    Chapter 13 Novel Translational Research of Neoadjuvant Endocrine Therapy
    Chapter 14 Alterations of Biomarkers by Neoadjuvant Endocrine Therapy
    Part V Preoperative chemotherapy
    Chapter 15 Essence of Neoadjuvant Therapy
    Chapter 16 The challenge to Overcome Triple Negative Breast Cancer Heterogeneity
    Chapter 17 Surgical Management of Breast Cancer after Preoperative Systemic Treatment
    Chapter 18 Imaging of Tumor Response by Preoperative Systemic Treatment
    Part VI Preoperative anti-HER2 therapy
    Chapter 19 Human Epidermal Growth Factor Receptor (HER) Family Molecular Structure
    Chapter 20 Locoregional Therapy Following Neoadjuvant Therapy for HER2-Positive Breast Cancer: Opportunities and Challenges
    Part VII Mathematical prediction/assessment model
    Chapter 21 Nomograms to predict positive resection margin and to predict 3 or more positive lymph nodes
    Chapter 22 Practical Use of Nomograms
    Chapter 23 Data Mining and Mathematical Model Development.
    Digital Access Springer 2016